KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Historic Change in Account Payables for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q2 2023 value amounting to -$6.7 million.

  • Ginkgo Bioworks Holdings' Change in Account Payables rose 5714.1% to -$6.7 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$18.5 million, marking a year-over-year decrease of 21766.09%. This contributed to the annual value of $4.8 million for FY2024, which is 50329.67% up from last year.
  • Ginkgo Bioworks Holdings' Change in Account Payables amounted to -$6.7 million in Q2 2023, which was up 5714.1% from $9.7 million recorded in Q1 2023.
  • Ginkgo Bioworks Holdings' 5-year Change in Account Payables high stood at $26.2 million for Q1 2022, and its period low was -$15.6 million during Q2 2022.
  • For the 4-year period, Ginkgo Bioworks Holdings' Change in Account Payables averaged around -$525363.6, with its median value being $516000.0 (2021).
  • Within the past 5 years, the most significant YoY rise in Ginkgo Bioworks Holdings' Change in Account Payables was 498720.93% (2022), while the steepest drop was 291240.46% (2022).
  • Quarter analysis of 4 years shows Ginkgo Bioworks Holdings' Change in Account Payables stood at $4.3 million in 2020, then tumbled by 87.87% to $524000.0 in 2021, then tumbled by 2912.4% to -$14.7 million in 2022, then soared by 54.63% to -$6.7 million in 2023.
  • Its Change in Account Payables stands at -$6.7 million for Q2 2023, versus $9.7 million for Q1 2023 and -$14.7 million for Q4 2022.